Cost of Treating to a Modified European Atherosclerosis Society LDL-C Target
| Autor: | R. Fellin, J.-M. Lecerf, L. M. Campbell, T. D. Szucs, C. Calvo, Dean G. Smith, S. McBride, S. J. Leslie |
|---|---|
| Rok vydání: | 1999 |
| Předmět: |
medicine.medical_specialty
business.industry Atorvastatin Pharmacology toxicology nutritional and metabolic diseases Low density lipoprotein cholesterol General Medicine Pharmacology Pharmacotherapy Endocrinology Simvastatin Internal medicine polycyclic compounds medicine European atherosclerosis society lipids (amino acids peptides and proteins) Pharmacology (medical) cardiovascular diseases business Pravastatin Fluvastatin medicine.drug |
| Zdroj: | Clinical Drug Investigation. 17:185-193 |
| ISSN: | 1173-2563 |
| DOI: | 10.2165/00044011-199917030-00003 |
| Popis: | Objective: To compare the costs of treating hypercholesterolaemic patients to a modified European Atherosclerosis Society low density lipoprotein cholesterol (LDL-C) target using atorvastatin, fluvastatin, pravastatin and simvastatin. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|